Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Psychol Serv ; 18(4): 651-662, 2021 Nov.
Article in English | MEDLINE | ID: mdl-32852996

ABSTRACT

Posttraumatic stress disorder (PTSD) clinics in the Department of Veterans Affairs (VA) often provide psychoeducational or skill-building groups to prepare veterans for trauma-focused PTSD treatments. However, there has been limited evaluation of the effectiveness of this phase-based approach for treatment engagement and symptom reduction. Participants included 575 veterans seeking treatment for PTSD whose treatment outcomes were assessed in a VA outpatient PTSD clinic staffed by mental health professionals and trainees. Participants completed self-report measures of baseline characteristics and psychiatric symptoms as part of routine PTSD clinic treatment. We tested the association of preparatory group treatment with engagement in and treatment response to subsequent trauma-focused psychotherapies, cognitive processing therapy (CPT) and prolonged exposure therapy (PE), which are designated by VA as evidence-based psychotherapies (EBP). Following participation in preparatory treatments, 94/391 (24%) of veterans engaged in a subsequent trauma-focused EBP (CPT or PE). Relative to patients who had previously completed a preparatory group, patients initiating a trauma-focused EBP without having first attended preparatory PTSD treatment had similar rates of trauma-focused EBP completion and better treatment response, as measured by decreases on the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5; PCL-5), F(1, 3009) = 10.89, p = .001, and Patient Health Questionnaire 9 measure of depressive symptoms F(1, 3688) = 6.74, p = .010. Overall, veterans reported greater symptom reduction when engaging in trauma-focused EBP directly, without having previously attended a preparatory group. These data support veteran engagement in trauma-focused EBPs for PTSD without first being encouraged to complete psychoeducational or skill-building groups. (PsycInfo Database Record (c) 2021 APA, all rights reserved).


Subject(s)
Implosive Therapy , Stress Disorders, Post-Traumatic , Veterans , Humans , Stress Disorders, Post-Traumatic/therapy , Treatment Outcome , United States , United States Department of Veterans Affairs
2.
J Behav Med ; 36(3): 328-39, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22569774

ABSTRACT

Women with a personal or maternal history of breast cancer experience psychological stress in relation to breast cancer risk, and adolescent and young adult daughters are particularly at risk for experiencing stress related to their mothers' history of breast cancer. The current study examined interpersonal and biological stress responses during a laboratory-based communication task about breast cancer risk in 32 mother-daughter dyads and explores whether certain communication styles between mothers and daughters are associated with increased stress reactivity during the task. Five saliva samples were collected from each participant to determine cortisol baseline levels, reactivity to, and recovery from the task. Negative maternal communication was associated with higher cortisol levels in daughters. In addition, maternal sadness was correlated with lower levels of daughters' cortisol at all time points with the exception of baseline measures. Implications for understanding the psychobiology of stress in women at risk for breast cancer are highlighted.


Subject(s)
Arousal/physiology , Breast Neoplasms/genetics , Breast Neoplasms/psychology , Communication , Genetic Predisposition to Disease/genetics , Genetic Predisposition to Disease/psychology , Health Education , Hydrocortisone/blood , Mother-Child Relations , Stress, Psychological/complications , Adolescent , Adult , Affect/physiology , Age Factors , Child , Female , Humans , Middle Aged , Risk Factors , Saliva/chemistry , Young Adult
3.
J Clin Sleep Med ; 6(5): 487-8, 2010 Oct 15.
Article in English | MEDLINE | ID: mdl-20957851

ABSTRACT

Following exposure to traumatic events, approximately 19% of combat veterans develop posttraumatic stress disorder. One of the main symptoms of this mental illness is reexperiencing the trauma, which is commonly expressed in the form of chronic trauma-related nightmares. In these patients, nightmares can fragment sleep, decrease sleep quality, and even cause fear about going to sleep. One promising psychological treatment for chronic nightmares is imagery rehearsal therapy. Imagery rehearsal therapy presumes that nightmares are a learned behavior and that activating the visual imagery system may facilitate emotional processing of the trauma. This treatment involves deliberately rewriting a nightmare and mentally rehearsing images from the newly rescripted scenario while awake. Imagery rehearsal therapy has been found to reduce nightmares and associated distress. We present a case study demonstrating the use of imagery rehearsal therapy in a Vietnam-era veteran with posttraumatic stress disorder and chronic nightmares. Nightmares were considerably reduced and the quality of sleep greatly improved after treatment.


Subject(s)
Dreams/psychology , Imagery, Psychotherapy/methods , Stress Disorders, Post-Traumatic/complications , Stress Disorders, Post-Traumatic/rehabilitation , Veterans/psychology , Vietnam Conflict , Aged , Humans , Male , Stress Disorders, Post-Traumatic/psychology , Treatment Outcome
4.
Arch Gen Psychiatry ; 61(10): 997-1004, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15466673

ABSTRACT

BACKGROUND: The effects of declining androgen secretion on mood regulation and the potential psychotropic efficacy of androgen replacement in men are largely undetermined. OBJECTIVE: To examine the effects on mood of the acute suppression of testosterone secretion. DESIGN: A double-blind, placebo-controlled, crossover (self-as-own-control) study. SETTING: An ambulatory care clinic in a research hospital. PARTICIPANTS: Thirty-one healthy adult men with no history of psychiatric illness or substance or anabolic steroid abuse. INTERVENTIONS: Men received depot leuprolide acetate (Lupron, 7.5 mg intramuscularly) every 4 weeks for 3 months. After the first month of Lupron alone, all men received (in addition to Lupron) testosterone enanthate (200 mg intramuscular) or placebo (sesame oil as color-matched vehicle) every 2 weeks for 1 month each in a crossover design. The order of administration of testosterone and placebo was randomly assigned and counterbalanced. MAIN OUTCOME MEASURES: Mood and behavior rating scores (self-report and rater administered). RESULTS: With the exceptions of hot flushes, libido, and the feeling of being emotionally charged, none of the symptoms measured showed a significant difference across eugonadal, Lupron plus placebo, and Lupron plus testosterone conditions. Despite the absence of a uniform effect of Lupron plus placebo on mood, 3 men experienced clinically relevant mood symptoms during this induced hypogonadal condition. High baseline levels of sexual functioning predicted the greatest decline in sexual function during Lupron plus placebo. CONCLUSIONS: These data, the first to describe the effects on mood of induced hypogonadism in healthy young men, suggest that short-term hypogonadism is sufficient to precipitate depressive symptoms in only a small minority of younger men. The predictors of this susceptibility remain to be determined.


Subject(s)
Affect/drug effects , Health Status , Hypogonadism/chemically induced , Hypogonadism/psychology , Leuprolide/pharmacology , Adult , Case-Control Studies , Cross-Over Studies , Delayed-Action Preparations , Double-Blind Method , Hormone Replacement Therapy/methods , Humans , Hypogonadism/blood , Libido/drug effects , Male , Middle Aged , Placebos , Sexual Behavior/drug effects , Sexual Dysfunctions, Psychological/chemically induced , Sexual Dysfunctions, Psychological/drug therapy , Sexual Dysfunctions, Psychological/psychology , Testosterone/analogs & derivatives , Testosterone/blood , Testosterone/pharmacology , Testosterone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...